Profil
Gautham Nadig was the founder of Metahelix Life Sciences Pvt Ltd. (founded in 2000, title: Director) and Mynvax Pvt Ltd. (founded in 2017, title: Executive Director).
Dr. Nadig is currently a Non-Executive Director at Ahammune Biosciences Pvt Ltd. Formerly, a Senior Scientist at Monsanto Co. Education includes a doctorate from the Indian Institute of Science.
Postes actifs de Gautham Nadig
| Sociétés | Poste | Début |
|---|---|---|
Ahammune Biosciences Pvt Ltd.
Ahammune Biosciences Pvt Ltd. Miscellaneous Commercial ServicesCommercial Services Engages in develop new treatment options for immune mediated diseases of the skin | Directeur/Membre du Conseil | - |
Mynvax Pvt Ltd.
Mynvax Pvt Ltd. BiotechnologyHealth Technology Operates as a biotechnology company | Fondateur | 01/01/2017 |
Anciens postes connus de Gautham Nadig
| Sociétés | Poste | Fin |
|---|---|---|
| MONSANTO | Directeur Technique/Scientifique/R&D | - |
Metahelix Life Sciences Pvt Ltd.
Metahelix Life Sciences Pvt Ltd. Agricultural Commodities/MillingProcess Industries Develops and markets hybrid crops and seeds | Fondateur | - |
Formation de Gautham Nadig
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Entreprise privées | 5 |
|---|---|
Monsanto Co.
Monsanto Co. Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology company controlling insects and weeds & manufactures seeds and genomics | Commercial Services |
Indian Institute of Science
Indian Institute of Science Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Metahelix Life Sciences Pvt Ltd.
Metahelix Life Sciences Pvt Ltd. Agricultural Commodities/MillingProcess Industries Develops and markets hybrid crops and seeds | Process Industries |
Mynvax Pvt Ltd.
Mynvax Pvt Ltd. BiotechnologyHealth Technology Operates as a biotechnology company | Health Technology |
Ahammune Biosciences Pvt Ltd.
Ahammune Biosciences Pvt Ltd. Miscellaneous Commercial ServicesCommercial Services Engages in develop new treatment options for immune mediated diseases of the skin | Commercial Services |
















